Reframing obesity-related HFpEF as a multiorgan syndrome: incretin-based therapies and imaging endpoints.

Mahmod M., Dennis A., Lian J., Langford C., Rahimi K., Wamil M.

DOI

10.1007/s10741-026-10629-z

Type

Journal article

Publication Date

2026-04-13T00:00:00+00:00

Volume

31

Keywords

Dual incretin agonists, GLP-1 receptor agonists, Heart failure with preserved ejection fraction (HFpEF), Magnetic resonance imaging (MRI), Multiorgan imaging, Obesity

Permalink More information Close